title: Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethane-anesthetized rats.
abstract: Corticotropin-releasing factor (CRF) injected peripherally or released in response to stressful challenges to the organism reduces gastric tone and contractility, in part by vagal pathways. However, information on the changes in gastric vagal impulse activity evoked by peripheral CRF administration is entirely lacking. Using a novel "dual recording" method in urethane-anesthetized rats, vagal efferent (VE) and afferent (VA) impulse activities were recorded simultaneously from separate, fine bundles dissected from the ventral gastric vagus nerve branch innervating the glandular stomach. Activity records for 38 VA single units (SUs) and 33 VE SUs were sorted from multiunit records obtained from 13 preparations. Intravenous (iv) administration of saline had no effect on multiunit VE activity, whereas CRF (1 microg/kg, iv) immediately inhibited VE activity, reaching a nadir of 54 +/- 8.0% of preinjection levels at 3.0 min postinjection. CRF (1 microg/kg, iv) inhibited 25/33 (75.8%) VE SUs and excited three of 33 (9.1%) VE SUs. In contrast to potent effects on VE activity, iv CRF did not alter multiunit VA activity. Single-unit analysis, however, revealed five of 38 (13.1%) VA SUs excited by iv CRF at widely varying latencies (suggesting an indirect mode of action) and one inhibited VA SU. VA SUs excited after iv CRF did not respond during gastric distention and vice versa. These experiments are the first to use simultaneous recording of gastric VA and VE units. The data demonstrate a predominantly inhibitory influence of iv CRF on VE outflow to the hindstomach, not driven by gastric vagovagal reflex activity.
authors.affiliation: Center for Ulcer Research and Education, Digestive Diseases Research Center, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, California 90073, USA. dadelson@ucla.edu
authors.forename: David W
authors.initials: DW
authors.lastname: Adelson
authors.forename: Hovsep P
authors.initials: HP
authors.lastname: Kosoyan
authors.forename: Yuhua
authors.initials: Y
authors.lastname: Wang
authors.forename: Justin Z
authors.initials: JZ
authors.lastname: Steinberg
authors.forename: Yvette
authors.initials: Y
authors.lastname: Taché
mesh_terms: D000758:Anesthesia; D018686:Anesthetics, Intravenous; D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D003627:Data Interpretation, Statistical; D004594:Electrophysiology; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009475:Neurons, Afferent / Q000187:drug effects* / Q000502:physiology; D009476:Neurons, Efferent / Q000187:drug effects* / Q000502:physiology; D010812:Physical Stimulation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012844:Sincalide / Q000494:pharmacology; D013270:Stomach / Q000294:innervation* / Q000502:physiology; D014520:Urethane; D014630:Vagus Nerve / Q000502:physiology*
chemical_list: D018686:Anesthetics, Intravenous; D014520:Urethane; D003346:Corticotropin-Releasing Hormone; D012844:Sincalide